1. Home
  2. ALDX vs MPA Comparison

ALDX vs MPA Comparison

Compare ALDX & MPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • MPA
  • Stock Information
  • Founded
  • ALDX 2004
  • MPA 1992
  • Country
  • ALDX United States
  • MPA United States
  • Employees
  • ALDX N/A
  • MPA N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • MPA Finance Companies
  • Sector
  • ALDX Health Care
  • MPA Finance
  • Exchange
  • ALDX Nasdaq
  • MPA Nasdaq
  • Market Cap
  • ALDX 160.8M
  • MPA 139.0M
  • IPO Year
  • ALDX 2014
  • MPA N/A
  • Fundamental
  • Price
  • ALDX $4.76
  • MPA $10.72
  • Analyst Decision
  • ALDX Strong Buy
  • MPA
  • Analyst Count
  • ALDX 2
  • MPA 0
  • Target Price
  • ALDX $9.50
  • MPA N/A
  • AVG Volume (30 Days)
  • ALDX 1.2M
  • MPA 25.2K
  • Earning Date
  • ALDX 07-31-2025
  • MPA 01-01-0001
  • Dividend Yield
  • ALDX N/A
  • MPA 3.83%
  • EPS Growth
  • ALDX N/A
  • MPA N/A
  • EPS
  • ALDX N/A
  • MPA N/A
  • Revenue
  • ALDX N/A
  • MPA N/A
  • Revenue This Year
  • ALDX N/A
  • MPA N/A
  • Revenue Next Year
  • ALDX N/A
  • MPA N/A
  • P/E Ratio
  • ALDX N/A
  • MPA N/A
  • Revenue Growth
  • ALDX N/A
  • MPA N/A
  • 52 Week Low
  • ALDX $1.14
  • MPA $9.87
  • 52 Week High
  • ALDX $7.20
  • MPA $12.21
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 78.74
  • MPA 44.98
  • Support Level
  • ALDX $4.12
  • MPA $10.74
  • Resistance Level
  • ALDX $4.60
  • MPA $10.76
  • Average True Range (ATR)
  • ALDX 0.29
  • MPA 0.07
  • MACD
  • ALDX 0.08
  • MPA 0.01
  • Stochastic Oscillator
  • ALDX 90.91
  • MPA 25.00

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

About MPA Blackrock MuniYield Pennsylvania Quality Fund

Blackrock Muniyield Pennsylvania Quality Fund is a closed-end fund with investment objective is to provide shareholders with current income exempt from U.S. federal and Pennsylvania income taxes.

Share on Social Networks: